Personalized health and the coronavirus vaccines—Do individual genetics matter?-Reference-Cited by-同舟云学术

Personalized health and the coronavirus vaccines—Do individual genetics matter?

Published:2021-07-26 Issue:9 Volume:43 Page:2100087
ISSN:0265-9247
Container-title:BioEssays
language:en
Short-container-title:BioEssays

Author:

Valdés‐Fernández Bianca N.¹²^ORCID,Duconge Jorge³,Espino Ana M.¹,Ruaño Gualberto⁴

Affiliation:

1. Department of Microbiology School of Medicine University of Puerto Rico‐Medical Sciences Campus San Juan Puerto Rico USA

2. Department of Biology University of Puerto Rico Rio Piedras Campus San Juan Puerto Rico USA

3. Department of Pharmaceutical Sciences School of Pharmacy University of Puerto Rico – Medical Sciences Campus San Juan Puerto Rico USA

4. Institute of Living at Hartford Hospital Hartford Connecticut USA

Funder

National Institute on Minority Health and Health Disparities

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bies.202100087

Reference57 articles.

1. Living with respiratory viruses: The next saga in human/viral coexistence?

2. Hepatitis B vaccination—immune response and persistence of protection in susceptible population;Kollathodi N.;Journal of The Academy of Clinical Microbiologists,2017

3. Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

4. Novavax. (2021).Annoucement of UK and South Africa Trial Results.

5. Pfizer. (n.d.).Vaccines and Related Biological Products Advisory Committee Meeting FDA Briefing.https://www.fda.gov/media/144245/download

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Vulnerability Index to Assess the Risk of SARS-CoV-2-Related Hospitalization/Death: Urgent Need for an Update after Diffusion of Anti-COVID Vaccines;Infectious Disease Reports;2024-03-15

2. The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine;Viruses;2024-01-26

3. The ethics of using COVID-19 host genomic information for clinical and public health decision-making: A survey of US health professionals;Human Genetics and Genomics Advances;2024-01

4. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines;Progress in Biophysics and Molecular Biology;2023-03

5. Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach;Frontiers in Immunology;2023-02-09